Pharmacoinvasive Strategy vs. Primary PCI in STEMI: A Prospective Registry in a Large Geographical Area

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

April 30, 2018

Primary Completion Date

July 14, 2020

Study Completion Date

July 14, 2020

Conditions
Myocardial Infarction, Acute
Interventions
OTHER

Primary percutaneous coronary intervention

Patient receives primary percutaneous coronary intervention as part of his treatment; decision to allocate by treating physician.

OTHER

Pharmacoinvasive strategy

Patient receives primary fibrinolysis and subsequent coronary angiography (pharmacoinvasive strategy) as part of his treatment; cases with failed fibrinolysis are scheduled for immediate rescue PCI. Decision to allocate by treating physician.

Trial Locations (1)

14030

"Instituto Nacional de Cardiología Ignacio Chavez", Mexico City

All Listed Sponsors
lead

Instituto Nacional de Cardiologia Ignacio Chavez

OTHER

NCT03974581 - Pharmacoinvasive Strategy vs. Primary PCI in STEMI: A Prospective Registry in a Large Geographical Area | Biotech Hunter | Biotech Hunter